1993 …2023
If you made any changes in Pure, your changes will be visible here soon.

Projects 1993 2023

Factor VIII
Genetic Therapy

OBI-1 Open Label

Reding, M. T.

OCTAGEN CORP

2/10/0512/31/07

Project: Research project

United States Health Resources and Services Administration
Hemophilia A
Serum Albumin
human F8 protein
Genetic Therapy
Safety

MASTER: TMH Network Master Site Agreement

Mc Cullough, J., Clay, M., Reding, M. T. & Steiner, M. E.

New England Research Institutes

9/1/078/31/14

Project: Research project

Blood Platelets
Hemorrhage

Clinical Trials in Transfusion Medicine and Hemostasis

Mc Cullough, J., Clay, M. & Reding, M. T.

NIH Nat'l Heart, Lung, and Blood Inst.

9/1/078/31/14

Project: Research project

Transfusion Medicine
Hemostasis
Clinical Trials
Neutropenia
Granulocytes
Infection
Hemophilia A
Observational Studies
Hemophilia B
Factor IX
Pharmacokinetics
Outcome Assessment (Health Care)
IB1001
Hemophilia A
Pharmacokinetics
Safety
BAY 94-9027
Hemophilia A
Hemorrhage
Safety
Therapeutics
Public Health Surveillance
Hemorrhage
Type 3 Von Willebrand's Disease
Factor VIII
Safety
Clinical Studies
human F8 protein
Hemophilia A
Safety
BAY 94-9027
Hemophilia B
Factor IX
Genetic Therapy
Viruses
Serogroup
Hemophilia B
Dependovirus
Factor IX
Genetic Therapy
Serogroup
Venous Thrombosis
Observational Studies
Orthopedics
Hemophilia B
Factor IX
Blood Coagulation Factors
Factor VIII
Hemophilia A
Phase III Clinical Trials
Hemophilia A
Pharmacokinetics
Safety
Hemophilia A
Registries
Patient Reported Outcome Measures
United States Health Resources and Services Administration
Factor VIII
Hemophilia A
Hemorrhage
Patient Reported Outcome Measures
United States Health Resources and Services Administration